446 related articles for article (PubMed ID: 19427670)
1. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
Li Y; Meng G; Huang L; Guo QN
Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
[TBL] [Abstract][Full Text] [Related]
2. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
3. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
4. Promoter-specific imprinting of the human insulin-like growth factor-II gene.
Vu TH; Hoffman AR
Nature; 1994 Oct; 371(6499):714-7. PubMed ID: 7935819
[TBL] [Abstract][Full Text] [Related]
5. Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma.
Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
Exp Cell Res; 2001 Oct; 270(1):88-95. PubMed ID: 11597130
[TBL] [Abstract][Full Text] [Related]
6. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma.
Yun K; Jinno Y; Sohda T; Niikawa N; Ikeda T
J Pathol; 1998 May; 185(1):91-8. PubMed ID: 9713365
[TBL] [Abstract][Full Text] [Related]
7. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression.
Dejeux E; Olaso R; Dousset B; Audebourg A; Gut IG; Terris B; Tost J
Endocr Relat Cancer; 2009 Sep; 16(3):939-52. PubMed ID: 19502451
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
11. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
12. Chromatin structure and imprinting: developmental control of DNase-I sensitivity in the mouse insulin-like growth factor 2 gene.
Feil R; Handel MA; Allen ND; Reik W
Dev Genet; 1995; 17(3):240-52. PubMed ID: 8565330
[TBL] [Abstract][Full Text] [Related]
13. Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development.
Li X; Gray SG; Flam F; Pietsch T; Ekström TJ
Int J Dev Biol; 1998 Jul; 42(5):687-93. PubMed ID: 9712523
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation trends in the intergenic region of the imprinted IGF2 and H19 genes in cloned cattle.
Curchoe CL; Zhang S; Yang L; Page R; Tian XC
Anim Reprod Sci; 2009 Dec; 116(3-4):213-25. PubMed ID: 19282114
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines.
Ooasa T; Karasaki H; Kanda H; Nomura K; Kitagawa T; Ogawa K
Mol Carcinog; 1998 Dec; 23(4):248-53. PubMed ID: 9869454
[TBL] [Abstract][Full Text] [Related]
17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
18. [The imprinting status and expression of insulin-like growth factor 2 gene in human hepatocellular carcinoma].
He WZ; Qin Y; Li B; Liu JY; Sun ZL; Sun ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):466-9. PubMed ID: 15291100
[TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
[TBL] [Abstract][Full Text] [Related]
20. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
Wu HK; Squire JA; Song Q; Weksberg R
Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
